Steven Cohen Point72 Asset Management
Steven Cohen is the founder of Point72 Asset Management and previously built SAC Capital into one of the industry’s most profitable trading firms. Point72 operates a multi-manager platform combining fundamental long/short equity with systematic and other strategies. Cohen is also a major figure in sports ownership and philanthropy, while remaining one of the most closely followed names in hedge fund trading culture.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$431M |
| 2 |
NVIDIA
NVDA
|
+$220M |
| 3 |
Micron Technology
MU
|
+$182M |
| 4 |
Union Pacific
UNP
|
+$168M |
| 5 |
Southern Company
SO
|
+$162M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$459M |
| 2 |
Meta Platforms (Facebook)
META
|
+$403M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$380M |
| 4 |
Salesforce
CRM
|
+$271M |
| 5 |
Intel
INTC
|
+$271M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.27% |
| 2 | Technology | 16.9% |
| 3 | Consumer Discretionary | 11.34% |
| 4 | Industrials | 9.63% |
| 5 | Energy | 5.73% |
Similar funds
Steven Cohen's Q2 2023 Portfolio in Review
As of Q2 2023, Steven Cohen held 2,962 positions worth $33.6B, up 4.1% from $32.3B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Steven Cohen withdrew a net $1.43B in Q2 2023, closing 858 positions and reducing 601 holdings. Its most notable exit was Prometheus Biosciences, Inc. Common Stock, an estimated $157M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 19% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Steven Cohen opened a new position in Micron Technology worth $178M.
- Steven Cohen's largest Q2 2023 buy was Micron Technology: 2,825,000 shares worth $178M.
- Steven Cohen added most to Microsoft in Q2 2023, an estimated $431M increase.
- Steven Cohen's biggest Q2 2023 reduction was Broadcom, cutting an estimated $459M.
- Steven Cohen fully exited Prometheus Biosciences, Inc. Common Stock in Q2 2023, selling an estimated $157M.
- Steven Cohen's ten largest holdings make up 14% of its $33.6B portfolio in Q2 2023.
- Steven Cohen opened 772 new positions and closed 858 in Q2 2023.
- Steven Cohen's portfolio value rose 4.1% quarter-over-quarter to $33.6B.
Based on Point72 Asset Management's 13F filing for Q2 2023, filed 14 Aug 2023.